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Abstract
Background: We have developed a culture system for the efficient and directed differentiation of
human embryonic stem cells (HESCs) to neural precursors and neurons.
HESC were maintained by manual passaging and were differentiated to a morphologically distinct
OCT-4+/SSEA-4- monolayer cell type prior to the derivation of embryoid bodies. Embryoid bodies
were grown in suspension in serum free conditions, in the presence of 50% conditioned medium
from the human hepatocarcinoma cell line HepG2 (MedII).
Results: A neural precursor population was observed within HESC derived serum free embryoid
bodies cultured in MedII conditioned medium, around 7–10 days after derivation. The neural
precursors were organized into rosettes comprised of a central cavity surrounded by ring of cells,
4 to 8 cells in width. The central cells within rosettes were proliferating, as indicated by the
presence of condensed mitotic chromosomes and by phosphoHistone H3 immunostaining. When
plated and maintained in adherent culture, the rosettes of neural precursors were surrounded by
large interwoven networks of neurites. Immunostaining demonstrated the expression of nestin in
rosettes and associated non-neuronal cell types, and a radial expression of Map-2 in rosettes.
Differentiated neurons expressed the markers Map-2 and Neurofilament H, and a subpopulation
of the neurons expressed tyrosine hydroxylase, a marker for dopaminergic neurons.
Conclusion:  This novel directed differentiation approach led to the efficient derivation of
neuronal cultures from HESCs, including the differentiation of tyrosine hydroxylase expressing
neurons. HESC were morphologically differentiated to a monolayer OCT-4+ cell type, which was
used to derive embryoid bodies directly into serum free conditions. Exposure to the MedII
conditioned medium enhanced the derivation of neural precursors, the first example of the effect
of this conditioned medium on HESC.
Background
Embryonic stem cells are pluripotent cells that can be
derived from the inner cell mass of the preimplantation
blastocyst [1,2]. Human ES cells have been isolated by
several groups and shown to be able to differentiate to cell
types representative of all three germ layers [3,4]. The gen-
eration of neural cultures from human embryonic stem
cells holds much promise for the investigation of human
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neurogenesis, the generation of neurons for pharmacolog-
ical testing and development of potential cell therapy
applications to treat neurological diseases such as Parkin-
son's Disease [5–7].
There have been several reports of neural differentiation
from HESCs, all of which rely on multi-step approaches
and stochastic differentiation as embryoid bodies [8,9] or
overgrowth of HESC cultures [3,10]. The disadvantages of
such approaches include inherent randomness within the
differentiation regime, which could lead to variability in
the mixed populations that are generated. This could have
unforeseen consequences for the proportions and charac-
teristics of specific neuronal subtypes that could be
derived. In addition, during the differentiation of ES cells
in embryoid bodies a layer of visceral endoderm forms on
the outside of the EB [11]. In vivo, the visceral endoderm
is known to be an important source of patterning and dif-
ferentiation signals [12]. A critical step in controlling
embryonic stem cell differentiation is overriding or elimi-
nating the early patterning information that is coming
from the visceral endoderm in the embryoid bodies.
An approach for directed neural differentiation of mouse
embryonic stem cells (MESCs) has recently been
described [13]. When mouse ES cells were differentiated
as embryoid bodies in the presence of the MedII condi-
tioned medium, an apparently homogeneous stratified
epithelium reminiscent of the positionally unspecified
neural tube was formed. This differentiation was pro-
posed to occur in the absence of potential signals from
extraembryonic endoderm or mesoderm and the neural
precursor population generated could therefore represent
a naïve population able to be manipulated to differentiate
along specific neural pathways.
It is not clear whether differentiation regimes developed
for mouse ES cells can be transferred to HESC cultures.
One approach that is likely to increase the control over the
neural differentiation of HESC cultures is the use of serum
free conditions. It is now clear that the emergence of neu-
ral lineages during mammalian development requires no,
or minimal, cell-extrinsic signalling. There is evidence for
an early FGF signal that is required to neuralize the epi-
blast cells in the chicken and cells within differentiating
MESC cultures [14,15]. At a low frequency MESCs can dif-
ferentiate into a primitive neural stem cell in serum free
conditions [16] and MESC-derived neural progenitors
thrive in serum free conditions that kill non-neural cell
types in differentiating MESC cultures [17]. An additional
important factor is FGF2, which has been shown to act as
a mitogen for human neural stem cells [18,19], and its
activity in enhancing human ES cell proliferation suggests
it could also be active in the neural differentiation of these
cells.
We have developed an alternate method for the differen-
tiation of neural cultures from HESC. This approach uses
an initial controlled differentiation of HESC cell colonies
while plated on mouse embryonic fibroblasts, followed
by suspension culture of embryoid bodies in serum free
conditions, in the presence of 50% MedII and FGF2.
Serum free embryoid bodies exposed to MedII (sfEB/
MedII) developed a neural precursor population that
exhibited characteristic rosette structures 7–10 days after
derivation. Parallel cultures not exposed to MedII (sfEB)
exhibited much reduced proportions of these neural
rosettes. Rosettes were comprised of a central cavity sur-
rounded by ring of cells, 4 to 8 cells in width, striking in
their similarity to neurectodermal populations derived
from mouse ES cells incubated in MedII. When plated and
grown in adherent culture, rosettes grew as circular or
ovoid radial structures that were nestin positive, and were
surrounded by large interwoven networks of neurons,
including presumptive dopaminergic tyrosine hydroxy-
lase positive neurons. This novel directed differentiation
approach led to the efficient derivation of neural cultures
from HESC and could provide cell populations for the
investigation of human neurogenesis, pharmacological
studies or cell therapy.
Results
Controlled early differentiation of human ES cells on 
mouse embryonic fibroblast feeder layers
Human ES cells can be grown on a layer of mouse embry-
onic fibroblasts (MEFs), where they form domed colonies
of undifferentiated cells (Fig. 1A, [3,4]). These cells
express high levels of the pluripotent marker protein
OCT-4 (Fig. 1C,1G), which is a nuclear-localized POU
domain transcription factor. We used the HESC lines
BG01 and BG02 [20] in this study, which were indistin-
guishable in terms of growth and differentiation charac-
teristics in the analysis described here. BG01 and BG02
were maintained on MEFs and passaged by cutting colo-
nies into cubes with drawn out glass needles. HESC cul-
ture systems are currently suboptimal and inherent
instability is often exhibited, with spontaneous and fre-
quent differentiation occurring within colonies, particu-
larly when the feeder layer is suboptimal or the culture has
overgrown. This instability has been used to differentiate
HESCs randomly, followed by manual isolation of neural
precursors from regions within differentiating colonies
[3,10]. In contrast to this essentially uncontrolled differ-
entiation, we observed that the colony morphology of
HESCs differed from the optimal, domed colonies when
they were passaged onto recently plated feeder cells. When
plated on feeder cells that were 0–6 hours old, but not on
feeders that were 2 days old or older, typical HESC colo-
nies formed except that in the central region of the colony
a "crater" was observed (Fig. 1B). These central cells
formed a uniform monolayer, within a ring of stackedBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
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Controlled early differentiation of human ES cell colonies Figure 1
Controlled early differentiation of human ES cell colonies (A) Undifferentiated HESC colony on mouse embryonic 
fibroblasts. (B) Crater containing colony derived from passaging HESC onto freshly plated mouse embryonic fibroblasts. A cen-
tral crater of monolayer cells (arrowhead) is surrounded by undifferentiated HESC (*), and differentiating cells in an outer ring 
adjacent to the feeders (arrow). (C,D) OCT-4 expression in undifferentiated HESC (C) and crater cells (D). (E,F) DAPI staining 
of the same fields as (C,D). (G,H) merged images of (C-F). Mitotic cells (arrowheads) and some of the apparently apoptotic 
cells (white dots) are indicated. (I) Anti-SSEA-4 immunostaining of a crater colony. Crater cells (arrowhead) do not stain for 
the SSEA-4 antigen, a marker of undifferentiated HESC, while the surrounding HESC are SSEA-4+ (arrow). Images and scale 
bars: (A,B) 10×, 100 µm. (C-H) 40×, 50 µm. (I) 10×, 100 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
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HESC surrounding the inner monolayer. The monolayer
was in direct contact with the tissue culture plastic, or the
extracellular matrix that was left behind as the HESC col-
ony had pushed out the underlying feeder layer. HESC
colonies typically displace the underlying feeder layer as
they proliferate over 3–5 days between passages. The
monolayer of cells within the "crater" (crater cells) main-
tained expression of the OCT-4 protein (Fig. 1D), but
were negative for the SSEA-4 antigen (Fig. 1I), a specific
marker of undifferentiated HESC [3,4]. Morphological
differentiation and loss of the SSEA-4 antigen, coupled
with maintenance of OCT-4 suggests that crater cells are
an alternate pluripotent cell population derived from
HESCs, or an early differentiation intermediate. Domed
HESC colonies could not be readily generated by passag-
ing of crater cells (not shown), also suggesting that crater
cells were not equivalent to undifferentiated HESC.
The flattened nuclear morphology of crater cells enabled
more information on the distribution of OCT-4 within
nuclei to be observed (Fig. 1D,1H), compared to undiffer-
entiated HESC (Fig. 1C,1G). For example, OCT-4
appeared to be occluded from some regions of the
nucleus. Also, the large majority of OCT-4 protein
appeared not to be associated with chromosomal DNA in
cells in the metaphase stage of mitosis. OCT-4 immunore-
activity was not observed in fragmented DAPI stained
nuclei, a likely indicator of apoptotic cells. Crater cells did
not express significant levels of the neural progenitor
markers nestin or vimentin (data not shown), which indi-
cated that they were not likely to represent a neural stem
cell or progenitor cell population. This data indicated that
crater cells could be generated in a controlled manner
from HESC within 3–5 days, and that they were essen-
tially morphologically uniform and homogeneous with
respect to OCT-4 expression and lacked SSEA-4 expres-
sion. This was in contrast to overgrowth of HESCs on
mouse feeder layers [3,10], where stochastic differentia-
tion proceeded over several weeks and led to a complex
heterogeneous culture from which neural progenitors
were manually isolated.
Efficient neural differentiation of HESC "crater cells" in 
suspension culture
MedII [21], medium conditioned by HepG2 cells, directs
the differentiation of mouse ES cells to a neurectodermal
population in an apparently homogenous manner [13].
We examined the neuronal differentiation of HESCs and
crater cells in response to FGF-2 or FGF-2/MedII, and a
summary of our morphological observations of the occur-
rence of neural precursor rosettes is shown in table 1.
When pieces of HESC colonies were used to generate
serum free embryoid bodies, rosettes of neural precursors
and differentiated neurons could be generated in suspen-
sion and when seeded to a polyornithine and laminin
matrix, but the culture was relatively heterogeneous, con-
taining many non-neural cell types (data not shown). In
contrast, when HESC derived crater cells were used, far
more uniform neural differentiation was observed. Crater
cells were purified by peeling the feeder layer and undif-
ferentiated stacked HESC colonies off of the culture dish
surface. Watchmaker's forceps were used to hold the
feeder layer at the side of the culture dish, and lift this
layer and attached HESCs from the dish. This manipula-
tion left the monolayer crater cells attached to the surface.
Monolayers of crater cells were cut into 50–200 cell size
pieces with glass needles and lifted from the dish. These
pieces were transferred to suspension in serum free condi-
tions, where they rounded up into embryoid body-like
masses and were referred to as sfEB (serum free embryoid
body) or sfEB/MedII (serum free embryoid body exposed
to MedII medium). After seven to ten days of suspension
culture, sfEB/MedII (Fig. 2A), but generally not sfEB (Fig.
2B), exhibited structured regions consisting of multiple
spherical rosette compartments. These were spherical
equivalents of the neural rosettes observed during subse-
quent adherent culture, and were strikingly similar to the
morphology exhibited by neurectoderm generated by the
differentiation of mouse ES cells in response to MedII
[13]. Sectioning and staining with toluidine blue or DAPI
demonstrated a characteristic structural organization
within sfEB/MedII. Multiple compartments were present
in each sfEB/MedII, each with a radial organization of
cells often surrounding a central inner cavity (Fig. 2C,2E).
The cell layer was typically 4 to 8 cells wide, with nuclei
that were elongated and aligned radially. DAPI staining of
rosette compartments revealed condensed mitotic chro-
mosomes in dividing cells lining the central core (Fig.
2F,2G), but not elsewhere, indicating that this is likely to
be a niche where the proliferative cells of the rosette
reside. Toluidine blue staining suggested the presence of
extracellular matrix lining the central core, and possibly
an additional layer surrounding the rosette unit (Fig. 2E).
Characteristic features of standard embryoid body differ-
entiations using serum were not exhibited by sfEB/MedII:
Table 1: Morphological Assessment of Neural Precursor 
Differentiation
MEDIA
CELLS FGF-2 FGF-2/MedII
Domed ES cell 
colonies
+/++ ++/+++
Crater cells +/+++ ++++/+++++
+, <10% aggregates exhibit neural precursor rosettes; +++++, >90% 
aggregates exhibit neural precursor rosettes as the major cell typeBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
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Differentiation of human ES cell derived crater cells in suspension culture in the presence of MedII conditioned medium Figure 2
Differentiation of human ES cell derived crater cells in suspension culture in the presence of MedII conditioned 
medium. Serum free EB/MedII and EB differentiated in suspension in the presence of FGF2/MedII (A) or FGF2 (B). Toluidine 
blue stained plastic sections of sfEB/MedII (C) and sfEB (D), a partial rosette in sfEB (arrowhead) is indicated. (E) sfEB/MedII 
rosette, higher magnification of boxed region shown in (C). Presumptive extracellular matrix in central cavity (red dots), and 
surrounding the rosette (green dot) are indicated. (F) DAPI stained sfEB/MedII rosette indicating the central core of prolifera-
tive cells. Condensed mitotic chromosomes are indicated by the arrowheads. (G) DAPI stained sfEB/MedII rosette indicating 
characteristic elongated radial nuclei and a centralized mitotic figure (arrowhead). (H) Percentage of DAPI stained rosette 
nuclei in sfEB (white column, 21+/-17%) and in sfEB/MedII (black column, 58.2+/-3.9%) (P < 0.02). Images and scale bars: (A,B) 
10×, 100 µm. (C,D) 20×, 50 µm. (E) 40×, 25 µm. (F,G) 60×, 10 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
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a well defined endodermal layer was not observed (Fig.
2A,2C), cysts developed rarely, and beating cardiomyo-
cytes were not observed. A non-rosette cell type(s) was
observed in occasional sfEB/MedII derived from crater
cells, present as rapidly proliferating regions that were not
organized into rosettes (Fig. 2C). Sectioning confirmed
the lack of organisation of this cell type, which character-
istically had small round nuclei, and could not be found
more than approximately 5 cell widths in from the edge of
a sfEB/MedII. When further in than this distance, intact
nuclei of this cell type(s) were not found, but fragmented
and apparently apoptotic/necrotic nuclei were observed.
In contrast, rosette cells could survive and proliferate deep
within a sfEB/MedII. SfEB/MedII derived from crater cells
were often comprised essentially entirely of rosette com-
partments, or if not, the rosettes could be identified and
manually selected for further culture by dissecting them
out of the sfEB/MedII.
To quantify the proportions of neural precursors and
other cell types in differentiations from crater cells, we
counted DAPI stained rosette nuclei and non-rosette
nuclei in sections of suspension aggregates (Fig. 2H). In
sfEB, the proportion of rosette nuclei was 21.8+/-17%
(1470/6715 nuclei), whereas in sfEB/MedII it was 58.2+/
-3.9% (3273/5678 nuclei) (P < 0.02). Along with reduced
proportions of neural precursor rosettes, sections of sfEB
demonstrated the presence of heterogeneous, poorly
organised cell types and cystic areas (Fig. 2D).
Neuronal differentiation of plated embryoid bodies grown 
in serum free medium
To test the ability of the rosette cells in the sfEB and sfEB/
MedII to differentiate into neurons they were plated on
polyornithine and laminin coated cell culture plates.
Robust adherent cultures of neurons resulted from plating
sfEB and sfEB/MedII, although exposure to MedII
enhanced the proportion of neural precursors and neu-
rons significantly (not shown). The embryoid bodies were
cut into pieces for plating, where they attached and flat-
tened, with proliferating cells and neuronal extensions
migrating out of the seeded pieces over the culture period.
SfEB and sfEB/MedII were seeded 3–5 days after deriva-
tion, prior to the observation of neural rosettes in suspen-
sion, or more than one week after initial derivation, when
distinct neural rosettes were formed in sfEB/MedII sus-
pension cultures.
When seeded within one week of derivation, cultures con-
sisting primarily of neural progenitor cell rosettes were
generated from sfEB/MedII. By observation of DAPI stain-
ing of 10–50 plated pieces we estimated that approxi-
mately 50–80% of the outgrowth area was comprised of
neural progenitor rosettes in plated sfEB/MedII, com-
pared with only 10–30% in sfEB. Other undefined cell
types were usually present in both conditions, but com-
prised a higher proportion of the culture in the absence of
MedII. Rosettes exhibited essentially the same characteris-
tics as seen in suspension culture, except that they gener-
ally formed essentially 2-dimensional arrays within or
surrounding the seeded embryoid body piece (Fig. 3A).
Rosettes could be observed as discrete units, or tightly
packed, with circular or ovoid appearance. Larger rosettes
typically contained a central depression or space, resem-
bling the cavity seen in rosettes in embryoid bodies.
Rosette cells were tightly packed and arrayed in a radial
pattern around the center. These cells had characteristic
elongated nuclei. The rosette radius was typically 4 to 8
cells wide, and cells could stack several cells high, without
being organized into distinct layers. Cells with morpholo-
gies consistent with early post-mitotic neurons were also
observed, most often closely associated with the outer
regions of rosettes. These cells exhibited a domed ovoid
cell body with a single neurite extending from each end
and dense networks of neurites could be observed (Fig.
3B). SfEB/MedII also contained variable levels of non-
rosette cells. These cells expressed nestin (Fig. 4C) and had
a high proliferative capacity. Unlike rosette cells, they
could be passaged by enzymatic digestion but were not
associated with a capacity for neuronal differentiation
(data not shown).
To determine the location of proliferating cells within the
neural rosettes, phospho-histone H3 immunostaining
was used to visualize mitotic cells in seeded cultures. This
modified form of Histone H3 is only found in cells under-
going mitosis [22,23]. In rosettes, phospho-H3 was
detected in cells lining or close to the center (Fig. 3C). As
expected, phospho-H3 staining was closely associated
with DAPI stained DNA and in many cases DAPI staining
also revealed condensed mitotic chromosomes. This is
consistent with our observation of mitotic figures in the
centre of rosettes in sfEB/MedII grown in suspension. This
demonstrated that the central region of rosettes is where
mitosis occurs and could be indicative of a neural stem
cell niche. In this scenario, neural stem cells in the center
of rosettes would be capable of proliferation to maintain
the stem cell state, or asymmetric division to derive
daughter cells where one is a stem cell and the other a dif-
ferentiating cell.
We also plated cells derived from sfEB and sfEB/MedII
that had been generated from the crater cells and cultured
for longer periods in suspension. These sfEB and sfEB/
MedII were plated after one week of suspension culture or
after culturing rosettes that had been dissected out from
sfEB/MedII and passaged in culture. In these cases exten-
sive networks of neurons were observed emanating from
the sfEB and sfEB/MedII pieces that had adhered to the
plate (not shown). The presence of MedII enhanced theBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
Page 7 of 13
(page number not for citation purposes)
generation of rosettes and associated neurons to around
the same extent as seen when pieces were seeded within
one week of derivation. Long neural extensions migrated
out from seeded pieces onto the polyornithine and lam-
inin matrix, or on top of other cell types that had prolifer-
ated or migrated out from the seeded piece.
Immunofluorescent staining was used to examine the
neuronal differentiation of sfEB and sfEB/MedII cultures
(Fig. 4). Nestin is an intermediate filament protein
expressed in the developing nervous system and is a
marker of neural stem/progenitor and stem cell popula-
tions [24,25]. Characteristic perinuclear patterns of nestin
expression were observed extensively in seeded sfEB and
sfEB/MedII cultures, including rosette cells and other
undefined cells outside of the rosettes (Fig. 4C). Vimentin,
another neural stem/progenitor marker [26] was
expressed in a similar profile (data not shown). Differen-
tiating neurons were identified by their expression of the
protein Map-2 (Fig. 4D,4H,4I,4J). Map-2+ neurons were
observed closely associated with the outer regions of
rosettes (Fig. 4H) and spanning their upper surfaces. Map-
2 was also expressed by rosette cells, in a striking radial
pattern (Fig. 4D,4H,4I). Co-expression of nestin and
MAP-2 has been noted previously in human fetal brain
cells [27,28]. The Map-2 expression pattern did not
appear to be organized into filaments, but could represent
a cytoplasmic stain in the tightly packed and elongated
rosette cells. That neurites exhibiting strong Map-2 expres-
sion were integrated with the outer regions of rosettes,
could indicate a progressive differentiation from a neuro-
nal precursor, to an early differentiated neuron, and to a
more highly differentiated neuron. Differentiated neu-
rons also expressed other characteristic neuronal markers
such as Neurofilament H (Fig. 5A). To determine if
dopaminergic differentiation occurred in plated sfEB/
MedII cultures derived from BG01 cells, immunofluores-
cent staining was performed using a sheep anti-tyrosine
hydroxylase (TH) antibody. Isolated TH+ neurons and
networks of TH+ neurons were observed in crater cell-
derived sfEB/MedII (Fig. 5B). Map2+/TH+ neurons were
observed, with a minor subpopulation of differentiated
neurons being TH+ (data not shown).
Discussion
In our HESC cultures, we regard undifferentiated HESC
colonies as those exhibiting a domed morphology, with
tight borders, and without overt organized structure
within the colony, which may signify differentiation.
These cells exhibit the expected pattern of pluripotent
marker expression: SSEA-1-, SSEA-3+, SSEA-4+, Tra-1-60+,
Tra-1-81+, OCT-4+ [20]. When plated onto freshly plated
fibroblast feeder layers, HESC colonies form as normal,
but after approximately 3 days, a central depression is
observable. This depression progresses over several days,
Phospho-Histone H3 expression in cultures derived from  plated sfEB/MedII Figure 3
Phospho-Histone H3 expression in cultures derived 
from plated sfEB/MedII. (A,B) Morphologies of a neural 
progenitor rosette (A) and of neurite networks (B). (C) 
PhosphoHistone H3 immunostaining (red) and DAPI overlay 
of a neural precursor rosette. Mitotic cells within rosettes 
are present in the central core region. Images and scale bars: 
(A,B) 40×, 50 µm. (C) 60×, 25 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
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Nestin and MAP-2 expression in cultures derived from plated sfEB/MedII Figure 4
Nestin and MAP-2 expression in cultures derived from plated sfEB/MedII. (A-E) and (F-I) represent images of two 
different fields. (A,F) Phase contrast image of rosettes, neurons and surrounding cells. (B,G) DAPI stained nuclei. (C) nestin 
expression in rosettes and surrounding cells. (D,H) Map-2 expression showing individual neurons and radial expression in 
rosettes (arrows). (I) Overlay of (G,H). (E) Overlay of (B-D). (J) An independent field showing Map-2 expression in a network 
of associated neurons. Images and scale bars: (A-J) 40×, 25 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
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to leave a central monolayer of cells. Colonies exhibiting
a central depression can be observed in HESC plated on
feeders that had been cultured for more than 2 days, but
these generally do not progress to a full crater morphology
unless the cultures are left to overgrow. Crater cells were
morphologically distinct from undifferentiated HESC,
retained expression of the pluirpotent marker OCT-4, but
did not exhibit the SSEA-4 antigen. This indicated that cra-
ter cells may be a partially differentiated, but still pluripo-
tent cell type, that is not distinguishable from
undifferentiated HESC on the basis of OCT-4 expression.
MESC can be directed to differentiate through pluripotent
cell intermediates when exposed to MedII [21], and this
has been used as a basis for defining markers that recog-
nise subpopulations within the OCT-4+ pool in vitro and
in vivo [29]. Additional markers are therefore likely to be
required to define subpopulations of pluripotent cells
derived from HESC.
The monolayer of crater cells could be harvested simply
by removing all other cells mechanically, by lifting off the
feeder layer. These crater cells could differentiate effi-
ciently to form neurons when cultured in embryoid body-
like aggregates in serum-free medium conditioned by
HepG2 cells (MedII conditioned medium). When placed
in suspension in the presence of MedII, morphologically
distinct rosette compartments formed, which, when
seeded to culture dishes, were shown to contain neuronal
precursor populations and associated differentiated neu-
rons. These cell types could form in the absence of MedII,
or from domed HESC colonies, but were formed at a
significantly higher frequency from crater cells exposed to
MedII. This may indicate that MedII does not contain neu-
ral inducing agents, but rather survival or proliferation
factors for neural precursor cells, and that crater cells have
a higher capacity to form neural precursors than domed
HESCs. It is possible that crater cells represent a more
homogeneous starting population than domed HESC col-
onies, which may explain their uniform neural differenti-
ation in response to MedII. However, crater cells were not
likely to represent a neural precursor population per se, as
they did not express appreciable levels of nestin or
vimentin, neural progenitor markers which were
expressed by rosette cells.
Our approach appears to be a more regulated method for
the generation of human neural precursors than the
uncontrolled differentiation of HESC cultures [3,10], or
the isolation of neural progenitors from seeded embryoid
bodies [4]. However, we have not yet been able to
dissociate rosettes to single cells to enable viable bulk pas-
saging of neural rosettes. This indicates that cell-cell inter-
action within the rosettes is critical for cell survival,
proliferation and differentiation. This is not unexpected
given their highly organized architecture and suggests that
sfEB/MedII culture may provide a model to investigate
human neural development. Human ES cells may be ame-
nable to precise genetic manipulation [30] and this sfEB/
MedII approach may enable the examination of the gene-
sis of neural precursors and rosettes. Furthermore, these
approaches could be coupled with lineage tracing of indi-
vidual cells within rosettes to analyze presumed cell fate
Neurofilament H and tyrosine hydroxylase expression in cul- tures derived from sfEB/MedII Figure 5
Neurofilament H and tyrosine hydroxylase expres-
sion in cultures derived from sfEB/MedII. (A) Neurofil-
ament H expression in neurons merged with DAPI staining of 
all nuclei. (B) Tyrosine hydroxylase expression in a small net-
work of neurons in plated sfEB(MedII) derived from BG01 
cells. The background fluorescence is caused by out of focus 
TH+ neurons. Anti-TH immunostaining was not performed 
on differentiations of BG02 cells. Images and scale bars: (A) 
40×, 25 µm. (B) 60×, 25 µm.BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
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decisions during self-renewal or progressive differentia-
tion to neurons.
It is not yet clear if sfEB/MedII rosettes represent equiva-
lent cell types to neural precursors that have been derived
previously from ES cells. Rosette compartments in sfEB/
MedII appeared very similar morphologically to the neu-
rectoderm population found in mouse EB/MedII [13],
which represent a positionally unspecified neuronal pre-
cursor population. If our neural precursor cells are also
positionally unspecified, variation of culture conditions,
exposure to soluble neuralizing factors or introduction of
transgenes could be used to direct differentiation of
rosette cells to alternate neuronal fates. Other described
neural precursors that may be similar include the
appearance of rosettes in seeded embryoid bodies [8], and
presumptive rosettes in the spontaneous uncontrolled dif-
ferentiation of HESCs [3,10]. The differentiation of
HESCs to neural rosettes has also been demonstrated fol-
lowing transplantation near the neural tube in a chick chi-
mera model [31]. These previous examples do not
describe approaches for the efficient derivation of neural
progenitor rosettes, which was a characteristic of sfEB/
MedII. One interpretation of our results suggests that neu-
ronal precursors are derived from HESCs and reside in the
central core of rosettes. Symmetric cell division may be
used for progenitor proliferation and asymmetric cell divi-
sion may generate an identical daughter neuronal progen-
itor and a differentiating cell that expresses a low level of
Map-2. This cell would be capable of migration away from
the core of the rosette and differentiation to a post-mitotic
neuron. In this scenario, the majority of the rosette would
consist of differentiating cells. Given the structural organ-
ization of rosettes and their differentiation capacity, it
would be interesting to define their relationship to struc-
tured neural progenitor niches in the embryo, such as
neuroepithilia, neurectoderm or the neural tube.
During the derivation and culture of sfEB/MedII, signifi-
cant cell death was not observed, indicating a direct con-
version of crater cells to neural precursors. Previously, a
default pathway of neural differentiation was suggested
for mouse ES cells [16], however only about 0.2% of sin-
gle ES cells could form neural stem cell colonies directly.
Cell-cell communication was not disrupted by dissocia-
tion at any time during our culture, which may have ena-
bled a community effect to enhance the proportion of
cells that could develop to neural fates. Conversely, the
development of crater colonies could represent a similar
significant selective step for undifferentiated human ES
cells. The generation of neural progenitors directly from
mouse ES cells required LIF, which was not an additive to
our culture medium. Rathjen et al have reported activity in
MedII equivalent to 50–100 U/ml human LIF [13,21] in
an assay for the conversion of mouse ES cells to EPL cells,
an alternate pluripotent cell state. Therefore it is possible
that our differentiation system relies on low levels of
human LIF, but the components of MedII that influence
neural differentiation have not been determined.
We are yet to examine the electrophysiological character-
istics of the neurons generated by this approach. However,
expression of neuronal markers Map-2 and Neurofila-
ment H [32] indicates that post mitotic neurons have
been generated. Their morphology and marker expression
is generally consistent with neurons derived from primate
ES cells in the presence of MedII, which exhibit the
expected electrophysiological properties [33].
Presumed dopaminergic neurons expressing the tyrosine
hydroxylase marker were generated from HESCs using this
approach. This demonstrated that exposure to MedII did
not restrict HESCs from dopaminergic differentiation and
suggests that further development of this approach may
enable the generation of populations suitable for cell ther-
apy applications in Parkinson's Disease. Such improve-
ments could possibly involve the enrichment of DA
precursors or neurons from our sfEB/MedII system by
selection or cell sorting, and the adaptation of HESCs or
rosette cells to bulk passaging methodologies to enable
large scale differentiation of neurons under the influence
of MedII.
Conclusions
We have developed a novel, controlled, neural differenti-
ation regime for human ES cells. HESC cultures were mor-
phologically differentiated to a novel OCT-4+ cell type,
"crater cells", which were differentiated to neural precur-
sors and neurons in a serum-free suspension culture sys-
tem. Neural progenitor populations that were organised
into rosette structures developed in the presence of the
conditioned medium MedII. These rosette cells expressed
nestin and could differentiate to neurons expressing the
markers Map-2, Neurofilament H or TH. This demon-
strated the efficient derivation of neural cultures from
HESC, for the examination of human neural development
and potential for using such differentiation approaches to
generate cell populations for cell therapy applications.
Methods
Human ES cell culture
The human embryonic stem cell lines BG01 and BG02
[20] were used in this work and were grown in DMEM/
F12 (50/50) supplemented with 15% FCS (HyClone), 5%
knockout serum replacer, 1× non-essential amino acids,
20 mM L-Glutamine, 0.5 U/ml penicillin, 0.5 U/ml strep-
tomycin, 10 ng/ml human LIF (Chemicon) and 4 ng/ml
FGF-2 (Sigma), (all from Gibco Invitrogen unless
otherwise labelled). HESC were grown on feeder layers of
mouse primary embryonic fibroblasts that wereBMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
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mitotically inactivated by treatment with mitomycin-C.
Tissue culture dishes were supplied by Falcon.
Mouse embryonic fibroblasts (MEFs) were prepared from
the ICR strain as described previously [34]. Explanted cells
were termed P0 (passage 0) and were frozen for storage.
Feeder cells were thawed, mitotically inactivated by treat-
ment with mitomycin-C, and re-plated at 1.2 × 106 cells
per 35 mm dish to generate P1 feeders. P1 MEFs were cul-
tured for at least 2 days prior to the plating of HESC for
routine culture. Human ES cells were grown as domed col-
onies and were manually passaged on to subsequent
fibroblast feeder layers every 3–4 days using a fire-pulled
Pasteur pipette. Briefly, the barrel of the Pasteur pipette
was melted solid and drawn out to a solid needle, which
was sequentially pressed through HESC colonies to form
a uniform grid of cuts, then under the colonies to lift them
from the feeder layer. Entire plates of HESC were har-
vested, then the colonies were broken into individual
pieces defined by the grid by gentle pipetting using a 5 ml
serological pipette. The pieces from a single plate were
split between 2 or 3 new plates that were coated with
feeder layers of mitotically inactivated mouse primary
embryonic fibroblasts.
Controlled differentiation of HESC and serum free 
embryoid bodies
For the controlled differentiation of HESC, pieces from
domed colonies were passaged to mitotically inactivated
mouse primary embryonic P1 fibroblasts within 6 hours
of when the feeder layer had been plated at 1.2 × 106 cells
per 35 mm dish. Under this condition, HESC colonies
grew as normal, but after ~4 days formed a central depres-
sion in the colony, which developed to become a crater of
a monolayer cell type surrounded by morphologically
normal HESC. This monolayer cell type was a presumed
early differentiation intermediate of HESC, and was used
to derive serum free embryoid bodies (sfEB, or "FGF-2"
conditions) or serum free embryoid bodies exposed to
50% MedII (sfEB/MedII, or "FGF-2/MedII" conditions).
MedII was generated from HepG2 cultures essentially as
described previously [21], using the serum free medium
DMEM/F12 (50/50) supplemented with 1 × N2 (Gibco
Invitrogen), 20 mM L-Glutamine, 0.5 U/ml penicillin,
and 0.5 U/ml streptomycin. FGF2 was included in all dif-
ferentiations as a mitogen and because of its known pro-
liferative effects on neural precursors [18,19]. Crater cells
were purified by removing the feeder layer and the HESCs
growing on the MEFs. Human ES cell crater cultures were
washed once with DMEM/F12, then watchmakers forceps
were used to hold the feeder layer at the side of the culture
dish, and lift this layer and attached HESC from the dish.
This manipulation peeled the feeder layer and the stacked
parts of the HESC colonies off of the dish and left behind
the monolayer crater cells which were attached to the
dish. Glass needles were used to cut the crater monolayers
to 50–200 cell size pieces, and lift them from the dish.
These pieces were grown in suspension culture in DMEM/
F12 (50/50), 1 × N2 (Gibco Invitrogen), 4 ng/ml FGF-2,
20 mM L-Glutamine, 0.5 U/ml penicillin, 0.5 U/ml strep-
tomycin, with or without 50% serum free MedII. Suspen-
sion cultures were incubated for up to six weeks, in
bacteriological dishes (Falcon) coated with 0.5% agarose
(Bio-Rad) in DMEM (Gibco Invitrogen), with replenish-
ment of the medium every 3–4 days. The serum free
embryoid bodies were passaged approximately every 7–
10 days by cutting them into pieces with drawn out solid
glass needles. At passaging, the embryoid bodies con-
tained approximately 5000–10,000 cells and were divided
into 4–10 pieces, discarding non rosette-structured
regions and rare cystic embryoid bodies.
Immunostaining
Serum free embryoid bodies (sfEB and sfEB/MedII) were
cut into pieces using glass needles and 1–15 pieces were
plated into wells of polyornithine (Sigma) and laminin
(Sigma) coated permanox chamber slides (Nalge Nunc)
in the same medium used for suspension culture. Coated
slides were prepared by diluting polyornithine to 20 µg/
ml in tissue culture grade water, coating chamber wells at
37°C overnight, washing twice with water and coating the
chamber wells with 1 µg/ml laminin at 37°C overnight.
The slides were washed with water and 1 × PBS (HyClone)
prior to plating the cells. The embryoid bodies were cul-
tured on these slides for 2–7 days.
For immunostaining, the cultures were rinsed with 1 ×
PBS and fixed in 4% paraformaldehyde (Fisher Scientfic),
4% sucrose (Sigma) in 1 × PBS for 30 minutes at 4°C. The
cells were then washed in 1 × PBS and stored at 4°C. The
cells were washed in block buffer (3% goat serum
(Gibco), 1% polyvinyl Pyrolidone (Sigma), 0.3% Triton
X-100 (Sigma) in wash buffer) for 30 minutes, and then
incubated with the appropriate dilution of the primary
antibody, or combination of antibodies for 4–6 hours at
room temperature.
The primary antibodies were: anti-Map2, a mouse mono-
clonal antibody (Sigma, Catalog # M4403) at a 1/500
dilution; anti-Nestin, a rabbit polyclonal antibody
(Chemicon, Catalog # AB5922) at a 1/200 dilution; anti-
OCT-4, a mouse monoclonal antibody (Santa Cruz, Cata-
log # sc-5279) at a 1/100 dilution; anti-Neurofilament H,
a mouse monoclonal antibody (Sternberger, Catalog #
SMI32) at a 1/500 dilution; anti-phosphoHistone H3, a
rabbit polyclonal antibody (Upstate, Catalog # 06-570) at
a 1/400 dilution; and anti-Tyrosine Hydroxylase, a sheep
polyclonal antibody (Pel-Freez, Catalog # P60101-0), at a
1/100 dilution, and anti-SSEA-4, a mouse monoclonal
antibody (Developmental Studies Hybridoma Bank,BMC Neuroscience 2003, 4 http://www.biomedcentral.com/1471-2202/4/27
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Catalog # MC-813-70) at a 1/5 dilution. For SSEA-4 cell
surface stainings, Triton X-100 was omitted from the
block and wash buffers.
The cells were washed 3 × 5 minutes in wash buffer (50
mM Tris-HCl pH 7.5 (Sigma), and 2.5 mM NaCl
(Sigma)). The cells were then incubated for a minimum of
2 hours in secondary antibodies diluted 1:1000, followed
by washing in wash buffer. The secondary antibodies were
Alexa-350 (blue), 488 (green) or 568 (red) conjugated
goat anti-rabbit, anti-sheep, or anti-mouse antibodies, all
available from Molecular Probes. The cells were stained
with 5 ng/ml DAPI (Sigma) to detect cell nuclei, and were
then washed from overnight to 2 days in a large volume of
wash buffer. The slides were mounted and visualized
using a either a NIKON TS100 inverted microscope or a
NIKON TE 2000-S inverted microscope with a Q Imaging
digital camera. Individual color channels were captured
separately and merged in Adobe Photoshop.
Histochemistry
For histochemical analysis, sfEB and sfEB/MedII were
fixed with 4% paraformaldehyde, 4% sucrose in 1 × PBS
for 30 minutes at 4°C. The cells were then washed in 1 ×
PBS and stored at 4°C. The serum free embryoid bodies
were embedded using the Immuno-Bed kit (Polysciences,
Inc., Catalog # 17324). Briefly, the PBS was removed and
the embryoid bodies were dehydrated by incubation in a
series of 25%, 50%, 75% Ethanol/1 × PBS for 5 minutes
at room temperature, followed by 100% Ethanol. Infiltra-
tion solution was made by adding 0.25 g Benzoyl Perox-
ide to 20 ml Immuno-Bed Solution A. The ethanol was
removed from the serum free embryoid bodies and 1 ml
infiltration solution was added. After one hour, the infil-
tration solution was changed for three 20 min incuba-
tions. For embedding, 1 ml solution B (accelerator) was
added to 25 ml fresh infiltration solution. The infiltration
solution was removed from the serum free embryoid
bodies and 0.5 ml embedding solution was added. The
samples were transferred to a mould, a block holder was
added and the mould was placed at 4°C to set. 3 micron
sections were cut using a Leica microtome, and were
stained with either 5 ng/ml DAPI (Sigma) in 1 × PBS, or
0.1% Toluidine Blue (Aldrich) in 30% Ethanol. Slides
were washed with 1 × PBS and visualised on a NIKON TE
2000-S inverted microscope with a Q Imaging digital cam-
era. For counting of DAPI stained rosette and non-rosette
nuclei, images of sections were captured on a NIKON
Eclipse E1000 compound microscope under a 10× objec-
tive and counted using the ImagePro software (Media
Cybernetics Inc.). The statistical comparison was a 2-
tailed t-test, assuming unequal variance.
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